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Background: Early-pregnancy short sleep duration is predictive of gestational diabetes and preeclampsia;
mechanisms for these associations are unknown. Leptin, an adipocyte-derived peptide involved in regulating food
intake and energy expenditure, may play a role in these observed associations. Given inconsistent reports linking
short sleep duration with leptin, and absence of studies among pregnant women, we examined the association of
maternal sleep duration with plasma leptin in early pregnancy.
Methods: This cross-sectional study included 830 pregnant women. Plasma leptin was measured in samples
collected around 13 weeks gestation. Sleep duration was categorized as: ≤5, 6, 7–8 (reference), and ≥9 hours.
Differences in leptin concentrations across categories were estimated using linear regression. Analyses were
completed for lean and overweight/obese women.
Results: Overall, women with long sleep duration had elevated plasma leptin (p-value = 0.04). However, leptin
concentrations were not statistically significantly elevated in women with a short sleep duration. There was no
association of leptin with sleep duration among lean women. Among overweight/obese women, a U-shaped
relation between leptin and sleep duration was observed: Mean leptin was elevated (β = 21.96 ng/ml, P < 0.001)
among women reporting ≤5 hour of sleep compared with reference group; and women reporting ≥9 hours of
sleep also had elevated leptin (β = 4.29 ng/ml, P = 0.09).
Conclusions: Short sleep duration, and to a lesser extent long sleep duration, were associated with elevated leptin
among overweight/obese women. These data add some evidence to help understand mechanistic relationships of
sleep duration with pregnancy complications.
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The worldwide prevalence of obesity has doubled since
1980 [1-3]; and this epidemic has been paralleled by a
trend in reduced sleep duration [4,5]. Mounting evidence
from both experimental and observational studies point
to short sleep duration as a risk factor for obesity and
obesity-related cardiometabolic disorders including meta-
bolic syndrome, type 2 diabetes, and cardiovascular disor-
ders [6,7]. Furthermore results from controlled metabolic
studies show that sleep is an important modulator of* Correspondence: Chun-fang.Qiu@Swedish.org
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reproduction in any medium, provided the orneuroendocrine function, glucose metabolism and the se-
cretion of appetite regulatory hormones.
Leptin, an adipocyte-derived hormone known to act on
hypothalamic receptors to regulate fat mass, reduce food
intake, increase energy expenditure, and stimulate thermo-
genesis [8,9], has recently been proposed as one possible
mechanistic link between decreased habitual sleep duration
and increased risk of obesity. Two research groups have re-
ported that shorter habitual sleep durations are associated
with reductions in fasting plasma leptin concentrations
and higher body mass index [10,11]. Additionally, a num-
ber of small clinical experimental studies reported de-
creases in plasma leptin following acute bouts of sleep
restriction [12-19]. However, at least two studies have. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ported increased leptin concentrations [22] following ex-
perimental sleep restriction. Hyperleptinaemia is also an
important clinical risk factor for adverse pregnancy out-
comes such as preeclampsia [23-25] and gestational dia-
betes mellitus [26]. At present, little is known about
modifiable factors that influence leptin concentrations in
maternal circulation during pregnancy.
Collectively, inference from these experimental studies,
however, have been limited in part by their small sample
size (with many having fewer than 12 participants), limited
generalizability (with many restricted to healthy young
males), and failure to account for changes in energy ex-
penditure and caloric intake during the experimental pe-
riods of observations. Additionally, none of the earlier
studies sought to evaluate the influence of habitual short
sleep duration on leptin concentration in pregnant women.
Given this gap in the literature, and given emerging evi-
dence of increased risks of adverse pregnancy outcomes
with habitual short sleep duration [27-29] and hyperlepti-
nemia [23-26], we sought to evaluate the extent to which,
if at all, maternal self-reports of habitual sleep duration
during early pregnancy is associated with early pregnancy
plasma leptin concentrations. Given emerging evidence
suggesting that women and overweight/obese individuals
may be particularly vulnerable to the physiological conse-
quences of sleep restriction [22], we also examined the ex-
tent to which observed association differ by maternal pre-
pregnancy lean or overweight/obesity status.
Results
Table 1 shows demographic characteristics of the 830
women in the study sample according to categories of re-
ported habitual sleep duration during early pregnancy.
Overall, maternal plasma leptin concentrations were cor-
related with systolic (r = 0.23), diastolic (r = 0.18), and
mean arterial blood pressure (r = 0.22) (all p-values <
0.001- data not shown). Similarly, maternal plasma leptin
concentrations were positively and statistically significantly
associated with higher plasma glucose concentrations after
a 50-gram oral glucose challenge screening test. Collect-
ively, these correlations are consistent with earlier reports
of associations of leptin with increased risks of preeclamp-
sia [23-25] and gestational diabetes [26].
Mean leptin concentrations were slightly higher among
groups of women classified as having short (≤5 hours) and
long (≥9 hours) sleep duration during early pregnancy
(Table 2). Mean leptin concentrations were lowest for
women who reported sleeping 7–8 hours per night during
early pregnancy (i.e., the reference group). Compared with
the reference group, women who reported sleeping
≤5 hours per night had a statistically non-significant eleva-
tion in plasma leptin (27.3 vs. 24.3 ng/ml, p-value = 0.43).
Women who reported sleeping ≥9 hours per night duringearly pregnancy, as compared with the reference group
had elevated leptin concentrations (27.0 vs. 24.3 ng/ml,
p-value = 0.04).
As shown in the bottom two panels in Table 2, the asso-
ciation between maternal sleep duration and leptin concen-
trations differed according to maternal pre-pregnancy lean
and overweight/obesity status. After stratifying the study
population according to lean (BMI <25 kg/m2) and over-
weight/obese women (≥25 kg/m2), we noted no association
of sleep duration with leptin concentrations among lean
women. However, among overweight women, we noted a
pronounced U-shaped relationship between plasma leptin
and sleep duration. Overweight/obese women who re-
ported sleeping ≤5 hours per night during early pregnancy
had substantially higher plasma leptin concentrations as
compared with those who reported sleeping 7–8 hours
per night (58.3 vs. 38.2 ng/ml, p-value <0.001). Com-
pared with women who reported sleeping 7–8 hours per
night (i.e., the reference group), those women who re-
ported sleeping ≥9 hours per night had increased leptin
concentrations, though the increase did not reach stat-
istical significance (43.0 vs. 38.2 ng/ml, p-value = 0.09).
Given evidence of different associations of sleep dur-
ation with leptin concentration, all further analyses
were completed for lean (BMI <25 kg/m2) and over-
weight/obese (≥25 kg/m2) women separately.
As shown in Table 3, associations between leptin con-
centration and short sleep duration among overweight/
obese women remained after adjustment for potential con-
founding by maternal age, race/ethnicity, and marital status
(Model 1). Notably, the associations remained statistically
significant, though somewhat attenuated, after maternal
pre-pregnancy BMI was included in the multivariable
model (Model 2). After controlling for all confounders,
short sleep duration during pregnancy (≤5 hours per night)
was associated with higher plasma concentrations on aver-
age (mean ± stand error [SE] 21.96 ± 5.30 ng/ml, p <0.001).
The fully adjusted model explained 25% of the variance in
leptin concentration (adjusted R2 = 0.25). Overweight/
obese women who reported sleeping ≥9 hours per night
also had elevated mean leptin concentrations (mean ± SE
4.29 ± 2.62 ng/ml, p = 0.09) though this association did not
reach statistical significance. Consistent with univariate
analyses, we observed no evidence of an association be-
tween sleep duration and leptin concentrations among lean
women (BMI <25 kg/m2). Further adjusting for blood pres-
sure in the 1st trimester did not change the estimates.
We next sought to further explore the curvilinear asso-
ciation between leptin concentrations and sleep duration
according to sleep duration among overweight/obese
women. There was a U-shaped relationship between hours
of sleep and leptin concentrations during early pregnancy
(Figure 1). However, the quadratic term for sleep duration
was not statistically significant (p = 0.18) in the adjusted
Table 1 Sociodemographic characteristics of the study population (N = 830) according to categories of self-reported
nightly sleep duration during early pregnancy
Categories of hours of sleep during pregnancy
≤ 5 hours 6 hour 7-8 hours ≥9 hours
Characteristics N = 28 N = 44 N = 485 N = 273
Maternal age (years) 29.6 ± 5.6 31.4 ± 4.1 32.0 ± 4.5 31.6 ± 4.6
18-25 6 (21.4) 3 (6.8) 23 (4.7) 9 (3.3)
25-34 16 (57.1) 33 (75.0) 331 (68.3) 193 (70.7)
≥ 35 6 (21.4) 8 (18.2) 131 (27.0) 71 (26.0)
Maternal race/Ethnicity
Non-Hispanic White 26 (92.9) 37 (84.1) 417 (86.0) 236 (86.5)
African American 0 (0.0) 3 (6.8) 10 (2.0) 3 (1.1)
Other 2 (7.1) 4 (9.1) 58 (12.0) 34 (12.4)
Payment status
Insurance 21 (75.0) 37 (84.1) 432 (89.1) 245 (89.7)
Medicaid 4 (14.3) 3 (6.8) 9 (1.8) 10 (3.7)
Missing 3 (10.7) 4 (9.1) 44 (9.1) 18 (6.6)
Nulliparous 23 (82.1) 34 (77.3) 408 (84.1) 252 (92.3)
Not married 11 (39.3) 6 (13.6) 54 (11.1) 27 (9.9)
< 12 years of education 3 (10.7) 1 (2.3) 27 (5.6) 10 (3.7)
Smoked during pregnancy 3 (10.7) 2 (4.6) 30 (6.2) 19 (7.0)
Physically inactive during pregnancy 8 (28.6) 5 (11.4) 81 (16.7) 46 (16.9)
Pre-pregnancy BMI 23.0 ± 4.8 22.3 ± 4.0 23.2 ± 4.8 23.7 ± 5.3
(kg/m2)
< 18.5 2 (7.1) 4 (9.1) 20 (4.1) 9 (3.3)
18.5 – 24.9 21 (75.0) 30 (68.2) 359 (74.0) 196 (71.8)
25-29.9 2 (7.1) 8 (18.2) 68 (14.0) 44 (16.1)
≥ 30.0 3 (10.7) 2 (4.5) 38 (7.9) 24 (8.8)
Mean systolic blood pressure in first trimester (mmHg) 114.2 ± 10.4 114.3 ± 9.4 112.5 ± 10.0 112.6 ± 10.2
Mean diastolic blood pressure in first trimester (mmHg) 69.2 ± 6.3 69.2 ± 7.0 70.3 ± 7.2 69.8 ± 7.0
Mean arterial blood pressure in first trimester (mmHg) 84.2 ± 6.9 84.2 ± 7.0 84.4 ± 7.3 84.1 ± 7.2
Gestational age at blood collection (weeks) 12.9 ± 3.0 14.5 ± 3.3 13.7 ± 3.5 13.6 ± 3.2
Data presented as mean ± SD or number (%).
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pre-pregnancy BMI.
Discussion
In this cross sectional study, we observed a U-shaped rela-
tionship between sleep duration and leptin concentrations
during early pregnancy among overweight/obese women.
In this population, women who reported sleeping ≤5 hours
per night had the highest plasma leptin concentrations in
early pregnancy (even after additional adjustment for pre-
pregnancy BMI). No such relationship was observed among
lean women.
We are unaware of published reports concerning the as-
sociation of sleep duration and leptin concentrations in
pregnant women. Our findings, however, are in generalagreement with results from some [22,30,31], though not
all [10,18,32], studies that have assessed leptin concentra-
tions in relation to habitual sleep duration or acute sleep
deprivation among men and non-pregnant women.
In an experimental study of 21 men and women
(instructed to not change their usual diet and allowed to
choose their meals from a standard meal), Pejovic and col-
leagues [30] found a 14% increase in 24-hour leptin levels
after one night of sleep deprivation. In a recent experi-
mental study involving 136 participants exposed to 5 con-
secutive nights of restricted sleep (4 hours of time in bed),
Simpson and colleagues noted that plasma leptin concen-
trations were statistically significantly increased during the
sleep deprived state as compared with baseline values [22].
In stratified analyses the authors noted that increases in
Table 2 Distribution of plasma leptin concentrations according to maternal self-reported nightly sleep duration during
early pregnancy
Early pregnancy Hours of sleep during pregnancy
Plasma leptin (ng/ml) ≤5 6 7-8 ≥9
All women (N) 28 44 485 273
Mean ± SD 27.3 ±19.7 24.3 ± 16.8 24.3 ± 17.1 27.0 ± 17.3
(p* = 0.43) (p* = 0.98) (Reference) (p* = 0.04)
**Lean women (N) 23 34 379 205
Mean ± SD 20.6 ± 14.1 19.9 ± 13.6 20.5 ± 14.7 21.7 ± 13.4
(p* = 0.98) (p* = 0.82) (Reference) (p* = 0.31)
**Overweight/obese women (N) 5 10 106 68
Mean ± SD 58.3 ± 8.0 39.1 ± 18.8 38.2 ± 18.6 43.0 ± 18.2
(p* < 0.001) (p* = 0.98) (Reference) (p* = 0.09)
*Pair-wise T-test p-value (each sleep duration group compared to reference group of 7–8 hours).
**Lean women (BMI <25 kg/m2); Overweight/Obese women (BMI ≥25 kg/m2).
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among women and participants with higher BMI as com-
pared with men and those with lower BMI, respectively
[22]. Our results are in agreement with these experimental
studies, particularly those that assess sleep duration and
leptin associations with consideration of possible hetero-
geneity according to BMI.Table 3 Relationship between maternal self-reported hours o
in early pregnancy: estimates linear regression coefficients fo
Tacoma, Washington, 1996-2000
Hours of sleep during pregnancy N MODEL 1
β SE (β) 95
All women
≤5 28 4.38 3.76 (−2.9
6 44 −0.05 2.56 (−5.0
7-8 485 Reference
≥9 273 2.60 1.30 (0.0
Adjusted R2 0.02
Lean women
≤5 23 1.24 2.85 (−4.3
6 34 −0.58 2.36 (−5.2
7-8 379 Reference
≥9 205 1.10 1.18 (−1.2
Adjusted R2 0.02
Overweight/obese women
≤5 5 24.99 4.06 (16.9
6 10 1.40 5.47 (−9.3
7-8 106 Reference
≥9 68 4.61 2.88 (−1.0
Adjusted R2 0.07
Separate models were fit for all, lean (BMI <25 kg/m2), and overweight BMI ≥25 kg/
Model 1: reported coefficients adjusted for maternal age, race/ethnicity, and marita
β, Estimated coefficient; SE (β), Standard error of the estimated coefficient; 95% CI, 9Our findings, however, are not in agreement with
other earlier studies [10,18,32]. For example, in their
short term partial sleep deprivation study, Spiegel and
colleagues reported short sleep was associated with re-
duction in leptin concentrations among lean men on a
controlled diet with constant glucose infusion [18]. Add-
itionally, in a cross sectional analysis from data based onf nightly sleep duration and plasma leptin concentrations
r the participants of the Omega Study, Seattle and
MODEL 2
% CI P-value β SE (β) 95% CI P-value
9, 11.76) 0.24 4.77 2.88 (−0.89, 10.43) 0.10
8, 4.98) 0.99 1.85 2.07 (−2.21, 5.91) 0.37
Reference
4, 5.16) 0.05 1.77 1.05 (−0.30, 3.83) 0.09
0.34
5,6.83) 0.66 1.81 2.84 (−3.76, 7.38) 0.52
3, 4.06) 0.81 1.47 2.26 (−2.96, 5.91) 0.51
Reference
2, 3.42) 0.35 0.86 1.09 (−1.28, 3.00) 0.43
0.15
7, 33.01) <0.001 21.96 5.30 (11.50, 32.43) <0.001
9, 12.20) 0.80 3.95 4.86 (−5.63, 13.53) 0.42
Reference
7, 10.30) 0.11 4.29 2.62 (−0.87, 9.46) 0.09
0.25
m2) women, respectively.
l status; and Model 2: Model 1 +maternal pre-pregnancy body mass index.
5% confidence interval.
Figure 1 Two-way quadratic prediction plots with 95%
confidence interval (gray shade) of predicted maternal plasma
leptin concentrations (green line) according to hours of sleep
during early pregnancy after adjusting for maternal age, race,
marital status and pre-pregnancy BMI.
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duced leptin concentrations in relation to reduced habit-
ual sleep duration [10]. In a recent study of 80 obese
men and pre-menopausal women, Knutson and col-
leagues observed no statistically significant associations
of relative leptin level (leptin concentration divided by
body fat percentage) with habitual sleep duration [32].
Several limitations merit discussion and consideration.
First, the cross sectional design of our study and the fact
that we did not directly measure maternal sleep duration
during pregnancy limited our ability to infer the temporal
relationship between sleep duration (or sleep quality), adi-
pose tissue mass and plasma leptin concentrations in early
pregnancy. Prospective studies of pregnant women that
include objective measures of sleep duration and maternal
adipose tissue mass are needed to demonstrate more con-
clusively these potential causal relationships. Second, a
single measurement of plasma leptin may be susceptible
to short-term variations, and thus is not likely to provide a
time-integrated measure of maternal leptin status during
early pregnancy. Consequently, results from our study, with
only one measurement of plasma leptin, may have been
biased. Longitudinal studies with serial measurements of
maternal plasma leptin concentrations are needed to ex-
pand upon our current findings. Third, measurement error
from the use of self-reported sleep duration is likely to have
occurred. However, this error is unlikely to have systematic-
ally biased our findings, because the reporting error is not
associated with the laboratory determination of maternal
plasma leptin concentrations. Misclassification of maternal
self-reported sleep duration (unrelated to our laboratory
measures of maternal plasma leptin concentrations) would
have served to underestimate the true association between
the two covariates. Fourth, diurnal variation in leptin con-
centration may have influenced our results. Becausesubjects were recruited and enrolled while they attended
obstetric clinics to receive standard prenatal care, and
because prolonged fasting is contraindicated during preg-
nancy, we were restricted to measuring leptin in non-
fasting blood samples. Finally, the limitation of the relative
small sample size in the category of overweight or obese
women having short sleep duration must be considered
when interpreting our study results.
The identification of leptin as a regulated secreted pep-
tide from adipocytes was a key development in the identifi-
cation of adipose tissue as an endocrine organ [8]. Despite
intense research, the precise metabolic and molecular
mechanisms by which leptin secretion is regulated remain
incompletely understood. Our findings along with those of
others [22] suggest that sleep may have a role in regulation
of leptin, particularly in overweight or obese individuals.
Given the central role leptin plays in regulating energy
homeostasis through central and peripheral mechanisms,
and that pregnancy represents a period of profound alter-
ations in glucose homeostasis and lipid metabolism, it
stands to reason that factors (such as sleep duration) that
may influence leptin concentrations in the non-pregnant
state may also play a role during pregnancy. Our findings
suggest that alterations in maternal leptin concentrations
may be related to habitual sleep duration in early preg-
nancy. Evaluation of alterations in leptin concentrations ac-
cording to changes in maternal sleep duration, for example,
may be one way of objectively assessing the physiological
impact of interventions designed to assess behavioral inter-
ventions designed to improve maternal sleep habits and
sleep hygiene during pregnancy.
Hyperleptinaemia is an important clinical risk factor for
preeclampsia [23-25] and gestational diabetes mellitus
[26]. Both disorders are associated with maternal adult
weight gain and pre-pregnancy weight gain [33-35]. At
present, little is known about modifiable factors that influ-
ence leptin concentrations in maternal circulation during
pregnancy.
Conclusions
Our findings suggest that sleep duration, a modifiable fac-
tor, and influences leptin concentrations in early preg-
nancy, particularly among overweight and obese women.
If confirmed, improved sleep habits, resulting in improve-
ments in sleep duration and quality, before and during
pregnancy may well be one important component in life-
style programs and strategies aimed towards disease pre-
vention and health promotion in all populations, including
pregnant women.
Methods
Study design and population
This analysis uses data initially gathered for the Omega
Study, a prospective study designed to examine the
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tional diabetes, and other pregnancy outcomes. The study
population was drawn from women attending prenatal
care at clinics affiliated with Swedish Medical Center
and Tacoma General Hospital in Seattle and Tacoma,
Washington, respectively. Recruiting began in December
1996. Women who initiated prenatal care before 16 weeks
gestation were eligible to participate. Women were ineli-
gible if they were younger than 18 years of age, did not
speak and read English, did not plan to carry the preg-
nancy to term or deliver at either of the two research
hospitals, and/or were past 16 weeks gestation.
Enrolled subjects were asked to participate in an inter-
view regarding sociodemographic and lifestyle characteris-
tics and medical and reproductive histories. Non-fasting
blood and urine specimens were collected, processed, and
stored during early pregnancy. Pregnancy outcome infor-
mation was abstracted from labor, delivery, and medical
records after the estimated delivery date. The procedures
used in this study were in agreement with the protocols
approved by the Institutional Review Boards of Swedish
Medical Center and Tacoma General Hospital. All partici-
pants provided written informed consent.
Analytical population
The analytical population is derived from participants who
enrolled in the Omega Study between 1996 and 2000. Dur-
ing this period, 1,219 eligible women were approached, and
1,000 (82 percent) agreed to participate. A total of 91
women with pre-gestational chronic hypertension and/or
multifetal pregnancies were excluded from the current ana-
lysis. Also excluded were 59 women with missing leptin
concentration values, and 20 women with incomplete infor-
mation on sleep duration during pregnancy. Thus, 830
women remained for analysis.
Data collection and sleep duration assessment
At the time of enrollment in the Omega study
(12.7 weeks gestation, on average), a 45 to 60 minute
structured questionnaire was administered by a trained
interviewer. Information on maternal sociodemographic,
medical, reproductive, and lifestyle characteristics includ-
ing average number of hours of sleep during early preg-
nancy was collected. Maternal average nightly sleep
duration during pregnancy was ascertained by asking
women the following question: “Since becoming pregnant,
how many hours per night do you sleep?” Responses
were reported as integers. Following the epidemiological
literature of sleep duration in adults, particularly avail-
able literature focused on pregnant women, we classified
participants into 4 sleep duration categories: ≤5 hours
(short duration), 6 hours (intermediate duration), 7–8 hours
(normal duration or reference group), and ≥9 hours (long
duration), respectively.Blood collection and plasma leptin measurements
At or near the time of interview (13.2 weeks gestation, on
average), a non-fasting blood sample was collected. Blood
was drawn into lavender-top vacutainer tubes containing
K3-EDTA (1 mg/ml). The tube was centrifuged at 850 g for
20 minutes at 4°C to separate red cells, white cells, and
plasma. Fractions were aliquoted and stored at −80°C until
analysis. Plasma leptin concentrations were measured using
an enzyme immunoassay (Diagnostic Systems Laboratory,
Inc., Webster, Texas, USA) with the intra- and inter-assay
coefficients of variation both <8%. All assays were com-
pleted without knowledge of maternal characteristics.
Statistical analyses
We examined the distributions of maternal sociodemo-
graphic, reproductive, and medical characteristics accord-
ing to four sleep duration categories. We then examined
distributions of plasma leptin concentrations and found
them to be approximately normal. We therefore reported
mean leptin concentrations across sleep duration categor-
ies. Spearman’s rank correlation coefficients were calcu-
lated to quantify associations between maternal early
pregnancy plasma leptin concentrations with first trimes-
ter systolic, diastolic and mean arterial blood pressure.
Correlations were also estimated to quantify the associ-
ation of leptin concentrations with plasma glucose con-
centration after a 50-gram oral glucose challenge.
Multivariable linear regression analyses with robust vari-
ances [36] were performed to evaluate the association
between sleep duration categories and plasma leptin con-
centrations. To assess confounding, we entered covariates
in Table 1 into a linear regression model sequentially, and
then compared the unadjusted and adjusted regression co-
efficients for sleep duration categories [37]. Final models in-
cluded covariates that altered unadjusted coefficients for by
10% or more, as well as covariates of a priori interest (i.e.,
maternal age). The following covariates were considered as
confounders in the final models: maternal age (<25, 25–34,
and ≥35 years), race/ethnicity (White, African American,
and Other), marital status (married vs. not married) pre-
pregnancy body mass index (BMI). Smoking was found not
to be the confounder in this analysis. To assess the poten-
tial modifying effects of maternal lean (<25 kg/m2) and
overweight/obesity (≥25 kg/m2) status on the relationships
between sleep duration and leptin concentrations, we fit
separate linear regression models for each group. We also
fit linear regression models with interaction terms between
sleep duration and maternal pre-pregnancy BMI. Adjusted
R2 values were calculated to measure the explanatory
power of each model, adjusted for degrees of freedom.
Next, to examine the nonlinear relationship of plasma
leptin concentrations and sleep duration in overweight
pregnant women, we treated the sleep hours as continu-
ous variable and fit a quadratic model by adding a
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the regression models. All analyses were performed using
Stata 9.0 statistical software (Stata, College Station, Texas,
USA). All continuous variables are presented as mean ±
standard deviation (SD), unless otherwise specified. All re-
ported p-values are two-tailed.
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